Stryker Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stryker Corporation on December 4, 2025. The filing discloses significant executive leadership changes and associated compensatory arrangements effective January 1, 2026.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive appointments and compensation details.
Material Changes
The primary material change is the appointment of new senior officers:
- Spencer Stiles: Appointed President and Chief Operating Officer (COO), succeeding his role as Group President, Orthopaedics.
- Dylan Crotty: Promoted to Group President, Orthopaedics, succeeding Mr. Stiles.
Compensation and Management Commentary
Letter agreements dated December 2, 2025, outline the following compensation terms effective January 1, 2026:
| Executive | Base Salary | Bonus Target | Long-Term Incentive (Target Value) |
|---|---|---|---|
| Spencer Stiles | $1,000,000 | 100% of base | ~$6,000,000 (40% options, 60% PSUs) |
| Dylan Crotty | $700,000 | 85% of base | ~$3,000,000 (40% options, 60% PSUs) |
Long-term incentive awards are subject to Board approval in February 2026. Stock options vest 20% annually over five years. Performance stock units vest following a three-year performance cycle.
Investor Verification Checklist
- Verify the final approval of long-term incentive awards by the Compensation and Human Capital Committee in February 2026.
- Review the full text of the Letter Agreements (Exhibits 10.1 and 10.2) for specific performance goals attached to the PSUs.
- Confirm the transition timeline for operational responsibilities between the outgoing and incoming officers.
- Check for any subsequent filings regarding changes to the executive compensation plan structure.